The involvement of L-arginine-nitric ox-ide-cGMP-ATP-sensitive K+ channel pathway in antinocicep-tion of BBHC, a novel diarylpentanoid analogue, in mice model
The present study focuses on the possible involvement of l-arginine-nitric oxide-cGMP-ATP-sensitive K+ channel pathway in the antinociceptive activity of a novel diarylpentanoid analogue, 2-benzoyl-6-(3-bromo-4-hydroxybenzylidene)cyclohexen-1-ol (BBHC) via a chemical nociceptive model in mice. The a...
Main Authors: | Hui, Ming Ong, Ahmad Azmi, Ahmad Farhan, Sze, Wei Leong, Abas, Faridah, Perimal, Enoch Kumar, Omar Farouk, Ahmad Akira, Israf Ali, Daud Ahmad, Sulaiman, Mohd Roslan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021
|
Online Access: | http://psasir.upm.edu.my/id/eprint/95511/1/The%20involvement%20of%20L-arginine-nitric%20ox-ide-cGMP-ATP-sensitive%20K%2B%20channel%20pathway%20in%20antinocicep-tion%20of%20BBHC%2C%20a%20novel%20diarylpentanoid%20analogue%2C%20in%20mice%20model.pdf |
Similar Items
-
The Involvement of <span style="font-variant: small-caps">l</span>-Arginine-Nitric Oxide-cGMP-ATP-Sensitive K<sup>+</sup> Channel Pathway in Antinociception of BBHC, a Novel Diarylpentanoid Analogue, in Mice Model
by: Hui Ming Ong, et al.
Published: (2021-12-01) -
Zerumbone-induced antinociception: involvement of the L-arginine-nitric oxide-cGMP -PKC-K+ ATP channel pathways.
by: Perimal, Enoch Kumar, et al.
Published: (2011) -
Zerumbone alleviates neuropathic pain through the involvement of L-arginine-nitric oxide-cGMP-K+ ATP channel pathways in chronic constriction injury in mice model
by: Zulazmi, Nurul Atiqah, et al.
Published: (2017) -
Antinociceptive activities of a novel diarylpentanoid analogue, 2-benzoyl-6-(3-bromo-4-hydroxybenzylidene)cyclohexen-1-ol, and its possible mechanisms of action in mice
by: Ong, Hui Ming, et al.
Published: (2021) -
The role of the L-arginine-NO-cGMP pathway in the development of tolerance to mephedrone-induced hyperlocomotion in mice
by: Bielecka-Papierz Gabriela, et al.
Published: (2023-06-01)